Crossmark

Intravenous 64zn-Aspartate Mitigates Neuroinflammation and Motor Dysfunction in an Lps-Induced Parkinson’s Disease Rat Model

Crossref DOI link: https://doi.org/10.1007/s11481-025-10257-8

Published Online: 2025-11-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Temnik, Max https://orcid.org/0009-0005-0503-6197
Rudyk, Mariia https://orcid.org/0000-0003-1252-885X
Balakin, Alexandr https://orcid.org/0000-0002-2542-1368
Gurin, Sergey https://orcid.org/0009-0005-7727-6712
Dovbynchuk, Taisa https://orcid.org/0000-0001-7451-6315
Byshovets, Roman https://orcid.org/0009-0001-2257-9792
Dzubenko, Nataliia https://orcid.org/0000-0002-2998-4168
Tolstanova, Ganna https://orcid.org/0000-0002-5286-5044
Skivka, Larysa https://orcid.org/0000-0002-2171-1085
License Information

Text and Data Mining valid from 2025-11-12

Version of Record valid from 2025-11-12
More Information

Article History

Received: 25 May 2025

Accepted: 29 September 2025

First Online: 12 November 2025

Declarations

:

: The authors declare no competing interests.